Last updated: 2026-10-19 00:21:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Mannkind Corporation (MNKD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.05, with a market capitalization of $977.50M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.23 to $6.51. This page covers its latest market performance, valuation, price trends and company information.
$977.50M | |
$3.20 | |
$121.55 | |
$0.67 | |
$3.19 | |
2.02M | |
4.56M | |
-- | |
$6.51 | |
$2.23 | |
-- | |
-- |
Mannkind Corporation (MNKD) last closed at $3.19 as of 2026-10-16 23:57:00, unchanged from the previous close of $3.19.
During the latest regular trading session, MNKD traded between $0.67 and $121.55, with a volume of 2.02M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Mannkind Corporation (MNKD) moved from $3.42 to $3.05, representing a decline of 10.96% ($0.38).
The stock traded between $2.90 and $3.53 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 4.53 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 19.0%
MNKD is currently trading at $3.05, placing it 19.0% of the way from its 52-week low of $2.23 to its 52-week high of $6.51. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 592 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Mannkind Corporation (MNKD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.